Half a Nation of Traitors
We Cannot Let These People Socialize Our Healthcare System
One of the DSA's Biggest Influencers Wants to Shred the Declaration of Independence,...
Mamdani: Priorities Tell You Everything
A Quick Bible Study Vol. 329: Death in the Old Testament
Their Evil Knows No Bounds
Iran Conflict Claims Another American Service Member's Life
Seattle Real Estate Owner Sentenced to 20 Months for Hiding $4.7 Million From...
When ‘Born-Again’ No Longer Means Transformed
The GOP's Path to Retaining Control of the House Is Here
Mississippi Man Pleads Guilty to Stealing Nearly $17K in SNAP Benefits
This Law Means That Praying at a Northern Ireland Hospital Could Land You...
Communism Versus the 10 Commandments
Big Tech’s Reckoning Is Here. Our Children Cannot Wait.
She Didn't 'Give Up' Her Child. She Made a Plan for Their Life.
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order
AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement